COSM: Cosmos Health Earnings growth forecast for next year

Graphic logo of Cosmos Health (COSM)

Cosmos Health Inc. (COSM) relies on a vertically integrated European distribution and pharmacy network. The valuation of future earnings per share reflects the current market trend, where 146.30 expresses the metric's value today. Growth prospects are based on the creation of personalized medical solutions through R&D, as well as the expansion of the dietary supplement portfolio through strategic partnerships with regional suppliers.

Cosmos Health, Inc. (COSM): Projected earnings per share growth rate for next year from 04/28/2023 to 11/12/2026

Analytical breakdowns for Cosmos Health Inc.

- share price and consensus valuation forecast:
Stock Price Cosmos Holdings|COSM - Broker Consensus Forecast
- market capitalization information:
Market Capitalization Cosmos Health|COSM - Company Buyout Price
- book capitalization indicators:
Net Assets per Single Share Cosmos Health|COSM - Accounting Capitalization|Market Capitalization to Book Value Ratio cosmosholdingsinc.com|COSM - Company Balance Sheet Assets
- debt and liquidity data:
Total Debt to Capital Cosmos Health Inc.|COSM - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Cosmos Health|COSM - Company Cumulative Debt|Debt to Book Capitalization Ratio Cosmos Health|COSM - Long-Term Debt Volume|Company Short-Term Debt Cosmos Health|Quick Liquidity cosmosholdingsinc.com
- net income and valuation ratios data:
COSM - Company Net Income|Expected Profit Cosmos Health Inc.|COSM - Business Payback Period|Projected Price to Earnings Cosmos Health Inc.|COSM - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Cosmos Health|COSM - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Cosmos Health|COSM - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth cosmosholdingsinc.com|COSM - Earnings growth in current year|Net earnings per share growth forecast for next year Cosmos Health Inc.
Fundamental company analysis:COSM, Cosmos Holdings
Finished products of Cosmos Health

The expansion strategy of Cosmos Health Inc. (COSM) through acquisitions in Europe directly impacts the expected earnings per share. This metric measures the percentage deviation of the projected EPS from its current value, reflecting market expectations regarding the efficiency of business scaling. The trend in the projected earnings per share for the coming year demonstrates a balance between the growth phase and the risks of asset overheating.

Competitor analysis

LLY (Eli Lilly & Co.) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ABBV (AbbVie Corp.)|Earnings growth forecast for next year AZN|Consensus forecast of earnings per share growth for next year novartis.com|Net earnings per share growth forecast for next year Merck MRK|NVO: Projected earnings per share growth rate for next year|Amgen Corporation - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Pfizer Corp (PFE)|SNY: Earnings growth forecast for next year|Expected earnings per share growth for next year bms.com|Net earnings per share growth forecast for next year GlaxoSmithKline plc|Expected net earnings per share growth next year Takeda Pharmaceutical Company TAK|Net earnings per share growth forecast for next year Teva Pharma (TEVA)|Consensus forecast of earnings per share growth for next year Dr. Reddy's Labs|Net earnings per share growth forecast for next year Viatris Inc. VTRS|ROIV - Expected earnings per share growth for next year|ZLAB - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Bausch Health Companies Inc.